H. Lee Moffitt Cancer Center and Research Institute: all 539 studies

Page 2 of 6. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.

• TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT03686488Phase 2Results posted
• Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03663166Phase 1/2Results posted
• Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal CancersCompletedNCT03656133Not applicableResults posted
• Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid CancerTerminatedNCT03630120Phase 2Results posted
• Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic LeukemiaCompletedNCT03575325Phase 2Results posted
• Ibrutinib and PD-1 Blockade in High Risk Lymphocytic LeukemiaTerminatedNCT03514017Phase 2Results posted
• Using MC1R Genotype to Impact Melanoma Risk BehaviorCompletedNCT03509467Not applicableResults posted
• Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed GlioblastomaCompletedNCT03426891Phase 1Results posted
• Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on LenalidomideTerminatedNCT03411031Phase 2Results posted
• Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)TerminatedNCT03406715Phase 2Results posted
• Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung CancerActive, not recruitingNCT03377023Phase 1/2Results posted
• Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaCompletedNCT03370276Phase 1/2Results posted
• Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal CancersCompletedNCT03332498Phase 1/2Results posted
• Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine TumorsCompletedNCT03290079Phase 2Results posted
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung CancerCompletedNCT03215810Phase 1Results posted
• Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast CancerTerminatedNCT03137693Not applicableResults posted
• Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast CancerCompletedNCT03112590Phase 1/2Results posted
• Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid NeoplasmsCompletedNCT03072043Phase 1/2Results posted
• Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell CarcinomaActive, not recruitingNCT03071406Phase 2Results posted
• Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung CancerCompletedNCT03043599Phase 1/2Results posted
• FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine CarcinomasTerminatedNCT03042780Phase 2Results posted
• Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCTCompletedNCT03018223Phase 1Results posted
• Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerCompletedNCT02964078Phase 2Results posted
• Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory SarcomaCompletedNCT02945800Phase 2Results posted
• Spanish-Language Smoking Cessation TrialCompletedNCT02945787Not applicableResults posted
• Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the BladderTerminatedNCT02901548Phase 2Results posted
• A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune SuppressionCompletedNCT02891603Phase 1/2Results posted
• Study of Nivolumab in Patients With Advanced Refractory Biliary Tract CancersCompletedNCT02829918Phase 2Results posted
• Facilitating Smoking Cessation With Reduced Nicotine CigarettesCompletedNCT02796391Phase 2Results posted
• Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple MyelomaCompletedNCT02780609Phase 1/2Results posted
• Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast CancerCompletedNCT02779855Phase 1/2Results posted
• Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT)CompletedNCT02722941Phase 2Results posted
• Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)Active, not recruitingNCT02638090Phase 1/2Results posted
• Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced CholangiocarcinomaCompletedNCT02631590Phase 2Results posted
• Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural MesotheliomaCompletedNCT02611037Phase 2Results posted
• Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) InterventionCompletedNCT02592447Not applicableResults posted
• Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) PreventionCompletedNCT02588339Phase 2Results posted
• TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast CancerCompletedNCT02586675Phase 1Results posted
• Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsCompletedNCT02575300Phase 2Results posted
• AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung CancerCompletedNCT02513563Phase 2Results posted
• Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and CyclophosphamideCompletedNCT02502864Phase 4Results posted
• Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian CancerCompletedNCT02440425Phase 2Results posted
• Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-CigarettesCompletedNCT02416011Not applicableResults posted
• Fermented Wheat Germ Extract in Women With Ovarian CancerTerminatedNCT02411565Early Phase 1Results posted
• Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC)CompletedNCT02402764Phase 2Results posted
• Focal Prostate Radio-Frequency AblationCompletedNCT02328807Not applicableResults posted
• Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade GliomasCompletedNCT02313272Phase 1Results posted
• Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerCompletedNCT02300610Phase 1Results posted
• Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell CarcinomaCompletedNCT02218164Phase 2Results posted
• Translating Extinction Research to Improve Pharmacotherapy for Tobacco DependenceCompletedNCT02202499Early Phase 1Results posted
• Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple MyelomaCompletedNCT02186834Phase 1/2Results posted
• Smoking Cessation for Cervical Cancer SurvivorsCompletedNCT02157610Not applicableResults posted
• Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast CancerCompletedNCT02139358Phase 1/2Results posted
• Single Agent Regorafenib in Refractory Advanced Biliary CancersCompletedNCT02115542Phase 2Results posted
• HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast CancerCompletedNCT02063724Phase 1Results posted
• Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV MelanomaCompletedNCT02032810Phase 1Results posted
• Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01999985Phase 1Results posted
• In Vivo Treg Expansion and Graft-Versus-Host Disease ProphylaxisCompletedNCT01927120Phase 2Results posted
• P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid SyndromeTerminatedNCT01886287Phase 2Results posted
• Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous TransplantCompletedNCT01852591Not applicableResults posted
• Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)CompletedNCT01842646Phase 2Results posted
• Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30TerminatedNCT01841021Not applicableResults posted
• COGNUTRIN in Breast Cancer SurvivorsCompletedNCT01823991Early Phase 1Results posted
• Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)CompletedNCT01822691Phase 2Results posted
• A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of RuxolitinibCompletedNCT01776723Phase 1/2Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT01713400Phase 2Results posted
• Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets PtsCompletedNCT01701674Not applicableResults posted
• Ofatumumab as Primary Therapy of Chronic Graft Versus Host DiseaseCompletedNCT01680965Phase 1/2Results posted
• Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic MelanomaCompletedNCT01659151Phase 2Results posted
• Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver MetsCompletedNCT01581307Phase 2Results posted
• Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSATerminatedNCT01531205Phase 2Results posted
• Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)CompletedNCT01497496Phase 2Results posted
• Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLLCompletedNCT01496976Phase 2Results posted
• Yervoy With Sylatron Unresectable Stage 3 or 4 MelanomaCompletedNCT01496807Phase 1Results posted
• Preparedness Study - HPV VaccineCompletedNCT01489527Not applicableResults posted
• Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LCTerminatedNCT01437605Phase 2Results posted
• A Study of Axitinib in Advanced Carcinoid TumorsCompletedNCT01435122Phase 2Results posted
• Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung CancerCompletedNCT01433172Phase 1/2Results posted
• Pomalidomide in Combination With High Dose Dexamethasone and Oral CyclophosphamideCompletedNCT01432600Phase 1/2Results posted
• Study of Gardasil in Mid-Adult Males (MAM)CompletedNCT01432574Phase 2Results posted
• Nuvigil or Placebo in Newly Diagnosed Malignant GliomaTerminatedNCT01400958Phase 2Results posted
• Oral Lenalidomide and Intravesical BCG for Therapy of Bladder CancerCompletedNCT01373294Phase 2Results posted
• Bicarbonate for Tumor Related PainTerminatedNCT01350583Not applicableResults posted
• Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)CompletedNCT01347034Phase 2Results posted
• Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)CompletedNCT01253161Phase 2Results posted
• Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for CholangiocarcinomaCompletedNCT01253148Not applicableResults posted
• Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDSCompletedNCT01133275Phase 2Results posted
• Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)CompletedNCT01111526Phase 1/2Results posted
• Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)TerminatedNCT01090973Phase 2Results posted
• Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple MyelomaCompletedNCT01054144Phase 2Results posted
• Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal SarcomasTerminatedNCT01048723Phase 2Results posted
• Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast CancerCompletedNCT01042535Phase 1/2Results posted
• Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, EffectivenessCompletedNCT01036321Phase 2Results posted
• Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaCompletedNCT01005745Not applicableResults posted
• Erlotinib Study for Myelodysplastic Syndrome (MDS)CompletedNCT00977548Phase 2Results posted
• Depocyt® With Sorafenib in Neoplastic MeningitisTerminatedNCT00964743Not applicableResults posted
• CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedNCT00955916Phase 2Results posted
• Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple MyelomaCompletedNCT00948922Phase 2Results posted
• Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target ModulationTerminatedNCT00858403Phase 2Results posted

← H. Lee Moffitt Cancer Center and Research Institute overview and focus areas